This bill mandates that Medicaid provide unrestricted coverage for medically necessary ovulation-enhancing drugs and related medical services for individuals aged 21 to 44 who are experiencing infertility. The coverage includes expenses for office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing, with a limit of three treatment cycles per beneficiary's lifetime. Infertility is defined as the inability to conceive after a specified duration of regular, unprotected sexual intercourse, and the bill emphasizes that this definition should not restrict access to treatment based on relationship status or sexual orientation.

Additionally, the bill amends Section 6 of P.L.1968, c.413 (C.30:4D-6) to include this new coverage under the Medicaid program, ensuring that payments for these services are made in full to providers without imposing additional charges on recipients. It also stipulates that no copayment or cost-sharing will be required from individuals eligible for medical assistance, except as mandated by federal law. The bill includes provisions for the Commissioner of Human Services to apply for necessary state plan amendments or waivers to implement these changes and secure federal funding, and it requires the Commissioner to adopt rules and regulations in accordance with the "Administrative Procedure Act." The act will take effect four months after its enactment, although anticipatory administrative actions may be taken beforehand.

Statutes affected:
Introduced: 30:4D-6